Christine L. Webb

1.1k total citations
16 papers, 643 citations indexed

About

Christine L. Webb is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Christine L. Webb has authored 16 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Surgery and 4 papers in Oncology. Recurrent topics in Christine L. Webb's work include Cholesterol and Lipid Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Christine L. Webb is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Christine L. Webb collaborates with scholars based in United States, United Kingdom and India. Christine L. Webb's co-authors include Paul G. Lysko, Andrew Zalewski, Damir Hamamdzic, Colin H. Macphee, James G. Bollinger, Mark Burgert, Yi Shi, Rosanna C. Mirabile, Jisheng Yang and Michael H. Gelb and has published in prestigious journals such as Nature Medicine, FEBS Letters and Journal of Lipid Research.

In The Last Decade

Christine L. Webb

15 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine L. Webb United States 11 260 220 125 111 108 16 643
B Paigen United States 4 248 1.0× 333 1.5× 162 1.3× 73 0.7× 168 1.6× 5 781
Hailing Liao United States 14 417 1.6× 283 1.3× 161 1.3× 120 1.1× 108 1.0× 18 811
Wendy S. Rosebury United States 11 496 1.9× 265 1.2× 128 1.0× 112 1.0× 97 0.9× 15 837
Sébastien Jacquet United Kingdom 12 501 1.9× 212 1.0× 90 0.7× 102 0.9× 85 0.8× 14 911
Yasutaka Ota Japan 8 235 0.9× 180 0.8× 95 0.8× 87 0.8× 93 0.9× 9 585
Fanny Robbesyn France 12 292 1.1× 178 0.8× 175 1.4× 67 0.6× 64 0.6× 15 707
Jack Wong United States 9 318 1.2× 182 0.8× 242 1.9× 52 0.5× 123 1.1× 9 736
Tetsuya Kitamine Japan 12 441 1.7× 355 1.6× 110 0.9× 125 1.1× 117 1.1× 14 789
Li‐Hao Huang United States 13 229 0.9× 175 0.8× 110 0.9× 84 0.8× 138 1.3× 18 676
Wenquan Hu China 16 356 1.4× 228 1.0× 117 0.9× 127 1.1× 119 1.1× 33 702

Countries citing papers authored by Christine L. Webb

Since Specialization
Citations

This map shows the geographic impact of Christine L. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine L. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine L. Webb more than expected).

Fields of papers citing papers by Christine L. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine L. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine L. Webb. The network helps show where Christine L. Webb may publish in the future.

Co-authorship network of co-authors of Christine L. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Christine L. Webb. A scholar is included among the top collaborators of Christine L. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine L. Webb. Christine L. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Washburn, David G., Tram H. Hoang, Nino Campobasso, et al.. (2009). Synthesis and SAR of potent LXR agonists containing an indole pharmacophore. Bioorganic & Medicinal Chemistry Letters. 19(4). 1097–1100. 15 indexed citations
2.
Marino, Joseph P., Lara S. Kallander, Chun Ma, et al.. (2009). The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages. Bioorganic & Medicinal Chemistry Letters. 19(19). 5617–5621. 6 indexed citations
3.
Wilensky, Robert L., Yi Shi, Emile R. Mohler, et al.. (2008). Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nature Medicine. 14(10). 1059–1066. 294 indexed citations
4.
Aravindhan, Karpagam, Christine L. Webb, Michael Jaye, et al.. (2006). Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study. Journal of Lipid Research. 47(6). 1250–1260. 23 indexed citations
5.
Johnston, Thomas P., Michael Jaye, Christine L. Webb, et al.. (2006). Poloxamer 407 (P-407)-mediated reduction in the gene expression of ATP-binding-cassette transporter A1 may contribute to increased cholesterol in peripheral tissues of P-407-treated rats. European Journal of Pharmacology. 536(3). 232–240. 14 indexed citations
6.
Lysko, Paul G., et al.. (2000). A Comparison of Carvedilol and Metoprolol Antioxidant Activities In Vitro. Journal of Cardiovascular Pharmacology. 36(2). 277–281. 54 indexed citations
7.
Elshourbagy, Nabil A., Xiaotong Li, Mitchell Gross, et al.. (2000). Molecular characterization of a human scavenger receptor, human MARCO. European Journal of Biochemistry. 267(3). 919–926. 37 indexed citations
8.
Wang, Xinkang, Theresa J. Reape, Xiang Li, et al.. (1999). Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low‐density lipoprotein and in atherosclerotic lesions. FEBS Letters. 462(1-2). 145–150. 88 indexed citations
9.
Lysko, Paul G., Joseph Weinstock, Christine L. Webb, Mary Brawner, & Nabil A. Elshourbagy. (1999). Identification of a Small-Molecule, Nonpeptide Macrophage Scavenger Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1277–1285. 27 indexed citations
10.
Lysko, Paul G., Kathryn A. Lysko, Christine L. Webb, et al.. (1998). Neuroprotective activities of carvedilol and a hydroxylated derivative. Biochemical Pharmacology. 56(12). 1645–1656. 27 indexed citations
11.
Lysko, Paul G., Christine L. Webb, & Giora Feuerstein. (1995). Binding of the nonpeptide antagonist, SB 209670, to endothelin receptors on cultured neurons. Peptides. 16(7). 1279–1282. 2 indexed citations
12.
Lysko, Paul G., Christine L. Webb, & G. Feuerstein. (1994). Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor. Neuroscience Letters. 171(1-2). 77–80. 21 indexed citations
13.
Lysko, Paul G., Kathryn A. Lysko, Christine L. Webb, & Giora Feuerstein. (1992). Neuroprotective effects of carvedilol, a new antihypertensive, at the receptor. Neuroscience Letters. 148(1-2). 34–38. 22 indexed citations
14.
Webb, Christine L. & Michael A. Eldon. (1991). Sensitive High-Performance Liquid Chromatographic (HPLC) Determination of Diphenhydramine in Plasma Using Fluorescence Detection. Pharmaceutical Research. 8(11). 1448–1451. 10 indexed citations
15.
Webb, Christine L. & Michael A. Eldon. (1987). Liquid Chromatographic Analysis of a New Antihypertensive Agent, PD 78,799, in Plasma on Silica Gel with Reversed-Phase Eluent. Journal of Liquid Chromatography. 10(11). 2513–2523. 2 indexed citations
16.
Eldon, Michael A. & Christine L. Webb. (1986). Liquid chromatographic analysis of a new antihypertensive agent, 3-{4-[4-(3-methylphenyl)-1-piperazinyl]butyl}-2,4-imidazolidinedione, in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 383(1). 194–200. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Paigen Breakdown of academic impact, for papers by Hailing Liao Breakdown of academic impact, for papers by Wendy S. Rosebury Breakdown of academic impact, for papers by Sébastien Jacquet Breakdown of academic impact, for papers by Yasutaka Ota Breakdown of academic impact, for papers by Fanny Robbesyn Breakdown of academic impact, for papers by Jack Wong Breakdown of academic impact, for papers by Tetsuya Kitamine Breakdown of academic impact, for papers by Li‐Hao Huang Breakdown of academic impact, for papers by Wenquan Hu
Rankless by CCL
2026